CLINICAL_TRIALS
trial_result
· 2020-02-28
Clinical Trial Update: Cannabinoid Medication for Adults With OCD [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial investigating a cannabinoid medication for adults with obsessive-compulsive disorder has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Obsessive-Compulsive Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-02-28